Zhou Y - Search Results

1

Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR/SHP/SREBP-1c axis.

Peng A, Liu S, Fang L, Zhu Z, Zhou Y, Yue S, Ma Z, Liu X, Xue S, Qiu Y, Qi R. Peng A, et al. Among authors: zhou y. Eur J Pharmacol. 2022 Apr 15;921:174841. doi: 10.1016/j.ejphar.2022.174841. Epub 2022 Mar 9. Eur J Pharmacol. 2022. PMID: 35278405

2

Epigenetic modification in alcohol-related liver diseases.

Ajoolabady A, Aslkhodapasandhokmabad H, Zhou Y, Ren J. Ajoolabady A, et al. Among authors: zhou y. Med Res Rev. 2022 Jul;42(4):1463-1491. doi: 10.1002/med.21881. Epub 2022 Feb 21. Med Res Rev. 2022. PMID: 35187693 Review.

3

wTAM: a web server for annotation of weighted human microRNAs.

Cui C, Fan R, Zhou Y, Cui Q. Cui C, et al. Among authors: zhou y. Bioinform Adv. 2021 Dec 7;2(1):vbab040. doi: 10.1093/bioadv/vbab040. eCollection 2022. Bioinform Adv. 2021. PMID: 36699401 Free PMC article.

4

JCAD deficiency delayed liver regenerative repair through the Hippo-YAP signalling pathway.

Zhang L, Yang YY, Xie L, Zhou Y, Zhong Z, Ding J, Wang ZH, Wang YL, Liu XP, Yu FX, Wu J. Zhang L, et al. Among authors: zhou y. Clin Transl Med. 2024 Mar;14(3):e1630. doi: 10.1002/ctm2.1630. Clin Transl Med. 2024. PMID: 38509842 Free PMC article.

5

DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives angiotensin II-induced vascular remodeling through regulating mitochondrial fragmentation.

Wang L, Wu L, Du Y, Wang X, Yang B, Guo S, Zhou Y, Xu Y, Yang S, Zhang Y, Ren J. Wang L, et al. Among authors: zhou y. Redox Biol. 2023 Nov;67:102893. doi: 10.1016/j.redox.2023.102893. Epub 2023 Sep 16. Redox Biol. 2023. PMID: 37741045 Free PMC article.

6

SpatialcoGCN: deconvolution and spatial information-aware simulation of spatial transcriptomics data via deep graph co-embedding.

Yin W, Wan Y, Zhou Y. Yin W, et al. Among authors: zhou y. Brief Bioinform. 2024 Mar 27;25(3):bbae130. doi: 10.1093/bib/bbae130. Brief Bioinform. 2024. PMID: 38557675 Free PMC article.

7

Centrosomal protein TAX1BP2 inhibits centrosome-microtubules aberrations induced by hepatitis B virus X oncoprotein.

Li SK, Tang HC, Leung MM, Zou W, Chan WL, Zhou Y, Ng IO, Ching YP. Li SK, et al. Among authors: zhou y. Cancer Lett. 2020 Nov 1;492:147-161. doi: 10.1016/j.canlet.2020.08.005. Epub 2020 Aug 19. Cancer Lett. 2020. PMID: 32827601

8

TEC kinase stabilizes PLK4 to promote liver cancer metastasis.

Yeung SF, Zhou Y, Zou W, Chan WL, Ching YP. Yeung SF, et al. Among authors: zhou y. Cancer Lett. 2022 Jan 1;524:70-81. doi: 10.1016/j.canlet.2021.08.038. Epub 2021 Oct 9. Cancer Lett. 2022. PMID: 34637843

9

Hedgehog Signaling, a Critical Pathway Governing the Development and Progression of Hepatocellular Carcinoma.

Ding J, Li HY, Zhang L, Zhou Y, Wu J. Ding J, et al. Among authors: zhou y. Cells. 2021 Jan 11;10(1):123. doi: 10.3390/cells10010123. Cells. 2021. PMID: 33440657 Free PMC article. Review.

10

PHB2 ameliorates Doxorubicin-induced cardiomyopathy through interaction with NDUFV2 and restoration of mitochondrial complex I function.

Yang M, Abudureyimu M, Wang X, Zhou Y, Zhang Y, Ren J. Yang M, et al. Among authors: zhou y. Redox Biol. 2023 Sep;65:102812. doi: 10.1016/j.redox.2023.102812. Epub 2023 Jul 12. Redox Biol. 2023. PMID: 37451140 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,804 results

Search Page

Filters